About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Daily Archives: November 29, 2007
Brief Update on Behind the Counter
A few weeks ago, on November 15, I reported on the public meeting held by the FDA to elicit input on the idea that drugs might have a new class beyond prescription and over-the-counter, called behind-the-counter, dispensed and, in essence, … Continue reading
Posted in FDA Policy
Comments Off on Brief Update on Behind the Counter